RENATA FLAKS: Open Payments
NPI 1548576853 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 32 payments from 8 companies in 2025. Trend: 2023 $349 · 2024 $1,080 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 10 | $163 |
| Novartis Pharmaceuticals Corporation | 6 | $138 |
| REVANCE THERAPEUTICS, INC. | 2 | $102 |
| Organon LLC | 7 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Incyte Corporation | 2 | $33 |
| Lilly USA, LLC | 1 | $17 |
Products named: DAXXIFY, VTAMA, Rhapsido, SPEVIGO, Zoryve, OPZELURA, TALTZ, COSENTYX.
Industry payments across NJ — which companies pay providers there.
